checkAd
    Startseite > Aktien > Vaxcyte > Nachrichten
    Vaxcyte Aktie
    63,50
     
    EUR
    -0,78 %
    -0,50 EUR
    Letzter Kurs 20:16:08 Tradegate
    63,00
     
    EUR
    160 STK
    Geldkurs 20:16:08
    63,50
     
    EUR
    160 STK
    Briefkurs 20:16:08
    ISIN: US92243G1085 · WKN: A2P6R6 · SYM: 5VA · USA

    Neueste Nachrichten

    Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update
    08.05.24 · globenewswire · Vaxcyte
    Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference
    02.04.24 · globenewswire · Vaxcyte
    Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants
    04.03.24 · globenewswire · Vaxcyte
    Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
    27.02.24 · globenewswire · Vaxcyte
    Vaxcyte to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
    15.02.24 · globenewswire · Vaxcyte
    Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
    03.02.24 · globenewswire · Vaxcyte
    Vaxcyte to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
    01.02.24 · globenewswire · Vaxcyte
    Vaxcyte Announces Pricing of $750 Million Public Offering
    31.01.24 · globenewswire · Vaxcyte
    Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
    30.01.24 · globenewswire · Vaxcyte
    Vaxcyte Completes Enrollment of Phase 1/2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease (IPD) in Adults Aged 50 and Older
    29.01.24 · globenewswire · Vaxcyte
    Vaxcyte Appoints Whitney Jones as Chief People Officer
    16.01.24 · globenewswire · Vaxcyte
    Vaxcyte Provides Clinical and Regulatory Progress Update on Potential Best-in-Class Pneumococcal Conjugate Vaccine (PCV) Franchise
    04.01.24 · globenewswire · Vaxcyte